| |
|
|
|
Catabasis Pharmaceuticals Inc.  
|
|
7.46 0.01 (0%) |
03-21 16:00 |
|
Open: |
7.38 |
Pre close: |
7.45 |
Target:
|
9.17 
|
|
High: |
7.85 |
Low: |
7.29 |
Resistance:
|
7.85
9.17
|
|
Volume: |
549,491 |
Market Cap: |
83M |
Support:
|
5.48
4.02
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.22
|
MACD |
MACD(12,26):
|
0.58 |
|
MA(20): |
5.66 |
Signal(12,26,9): |
0.31 |
|
MA(100): |
5.64 |
Stochastic Oscillator |
%K(14,3):
|
86.89  |
|
MA(250): |
8.97 |
%D(3): |
88.33 |
|
Average Volume(K) |
3-Month: |
27598
|
52-Week |
High:
|
20.40 |
|
10-Days: |
40994 |
Low: |
0.39 |
|
RSI |
RSI(14):
|
76.95 |
Change(%): |
-63.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-6.550 |
Return on Equity (ttm) |
-90.1 |
Shares Out. (M) |
7.50 |
|
EPS Est. Current Year |
-1.390 |
Return on Assets (ttm) |
-74.4 |
Shares Float (M) |
6.99 |
|
EPS Est. Next Year |
-1.100 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.70 |
|
EPS Est. Next Quarter |
-0.330 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
250.80 |
|
Forward EPS |
-1.190 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
1.070 |
EBITDA (p.s.) |
0.000 |
P/E |
-1.14 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
6.97 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-23.83 |
P/S |
1385073280.00 |
|
Operating Margin |
-9938.00 |
Levered Free Cash Flow
(M) |
-13.96 |
P/CF |
-2.35 |
|
|
|
|
|
|
